近期老挝新冠疫情加重，老挝塞林生物科技有限公司（Sailin）向老挝政府部门及医院捐赠价值340,000,000kip防疫物资（中国自主研发新型冠状病毒消毒液）。
老挝103医院
老挝150医院
老挝国防部
老挝公安部
老日医院
老中医院（玛霍索医院）
武汉京创崇高生物技术有限公司是一家致力于剩余安全防护技术研发的高科技企业，集微生物学、医学、纳米化学、抗菌抗病毒高新材料等为一体.
其中1999年完成国家国家重点火炬项目“抗菌母粒研制生产应用”；2003年京创崇高李毕忠博士完成抗病毒医用防护服，防护口罩的研制；2009年完成H1N1甲型流感、H5N1禽流感医用防护产品的研制；2020年核心团队成功研制抗冠状病毒口罩、消毒液等系列产品，并通过专业检测。
经中国科学院权威专业机构检测， 本消毒液产品可直接灭杀新型冠状病毒（SARS-CoV-2）。本品为100ml装喷剂，使用本消毒液进行肤表、物表、空间消杀， 喷一次，可以保持7天长时间的灭杀效果。本消毒液可灭杀新型冠状病毒外，经普林机构检测认证，还具备抗甲型H1N1流感病毒、禽流感H5N1病毒、 肠道致病菌、化脓性球菌、致病性酵母菌、腺病毒等医学常见细菌、病毒。安全测试无毒无刺激。
Recently, the new crown epidemic in Laos has worsened, and Laos Sailin Biotechnology Co., Ltd. donated 340,000,000kip defensive substances (China's independent research and development of new coronavirus disinfectant) to Lao government departments and hospitals.
Laos 103 Hospital
Laos 150 Hospital
Laos Ministry of Defence
Ministry of Public Security of Laos
Laori Hospital
Old Chinese Hospital（Mahoso Hospital）
Wuhan Jingchuang Chonggao Biotechnology Co., Ltd. is a high-tech enterprise dedicated to the research and development of residual safety protection technology, integrating microbiology, medicine, nanochemistry, antibacterial and antiviral high-tech materials, etc.
Among them, in 1999, the national key torch project "development, production and application of antibacterial masterbatches" was completed; in 2003, Dr. Li Bizhong, Jingchuang Sublime, completed the development of anti-viral medical protective clothing and protective masks; in 2009, completed H1N1 influenza A and H5N1 avian influenza medical protection Product development: In 2020, the core team successfully developed a series of products such as anti-coronavirus masks and disinfectants, and passed professional testing
